Jul. 20 at 10:22 PM
$SBEV it’s time to start really focusing on SBEV, this isn’t the same Co anymore. A lot has happened the last month and with this Argent CannEpil agreement. The significance is being grossly undervalued. JAZZ bought GW Pharmaceutical for
$7.2 BILLION dollars for Epidiolex whatever the same Medical Treatment as CannEpil, CannEpil is already a revenue producing Treatment in other Countries.. Argent has already had a
$300 million plus valuation in 2025. With over 80% of the debt wiped away I think it’s time to get excited here!
✅ Acquired a 20 Year Licensing Agreement for CannEpil (The therapy is manufactured under European Union Good Manufacturing Practice (EU-GMP) standards and benefits from an existing international distribution infrastructure)
